FLARE: A Systematic, Uncertainty-Aware Framework for Evidence-Based Adoption of Artificial Intelligence in Healthcare
FLARE is a systematic, uncertainty-aware framework for evaluating the financial and operational implications of adopting AI in healthcare, moving beyond model accuracy to assess real-world economic viability The framework integrates fuzzy logic, time-driven activity-based costing, and return on investment analysis to quantify clinical service delivery costs, AI development/operational costs, and workflow integration consequences under uncertainty Case study on AI-assisted large vessel occlusion
Analysis
TL;DR
- FLARE is a systematic, uncertainty-aware framework for evaluating the financial and operational implications of adopting AI in healthcare, moving beyond model accuracy to assess real-world economic viability
- The framework integrates fuzzy logic, time-driven activity-based costing, and return on investment analysis to quantify clinical service delivery costs, AI development/operational costs, and workflow integration consequences under uncertainty
- Case study on AI-assisted large vessel occlusion detection in CT stroke pathways identified a break-even threshold of approximately 3,992 patients per year, with positive first-year ROI at typical volumes of ~5,000 patients
- Economic benefit depends on multiple factors beyond algorithmic performance, including patient volume, verification time, infrastructure choices, and workflow design
- FLARE provides a transparent decision-support tool for clinicians, administrators, and policymakers to determine when AI deployment is economically viable and where operational changes may improve value
Why It Matters
This framework addresses a critical gap in AI healthcare adoption: the overemphasis on model accuracy metrics without considering whether deployment is economically worthwhile in real clinical settings. By making uncertainty, resource use, and implementation trade-offs explicit, FLARE gives healthcare decision-makers a practical tool for early-stage health technology assessment that bridges the divide between technical performance and operational viability.
Technical Details
- FLARE combines three core methodologies: fuzzy logic for handling uncertainty in input parameters, time-driven activity-based costing (TDABC) for estimating clinical service delivery costs, and return on investment (ROI) analysis for evaluating economic consequences
- The framework quantifies three cost categories within a unified activity-based model: conventional pathway costs, AI-related development and recurring operational costs, and AI-enabled service savings
- Case study application focused on AI-assisted large vessel occlusion detection in the CT stroke pathway for acute ischemic stroke, demonstrating how the model captures both fixed and variable cost components across the clinical workflow
- Break-even analysis identified approximately 3,992 patients per year as the threshold for economic viability, with positive first-year ROI achievable at typical annual stroke volumes of about 5,000 patients
- The model explicitly incorporates uncertainty through fuzzy logic, allowing for range-based estimates rather than point estimates, which better reflects real-world variability in clinical settings
Industry Insight
- Healthcare organizations should adopt structured economic evaluation frameworks like FLARE before committing to AI procurement, as algorithmic performance alone does not guarantee cost-effectiveness or positive ROI
- Investment in AI healthcare deployment should be strategically aligned with patient volume thresholds and workflow redesign opportunities, as economic benefit is highly sensitive to operational factors beyond model accuracy
- Policymakers and health technology assessment bodies should consider standardizing uncertainty-aware economic evaluation frameworks to create more consistent and transparent criteria for AI adoption decisions across healthcare systems
Disclaimer: The above content is generated by AI and is for reference only.